Cysteamine Hydrochloride

CHEMBL1256137 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
113.6 g/mol
LogP
Phase
4

A hydrochloride salt of cysteamine used to treat cystinosis, a rare inherited disorder where an amino acid builds up and damages organs. It works by reducing cystine accumulation within cells.

Moleküler Ağırlık

113,6100 g/mol

TPSA

27,00 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.NCCS

InChI

InChI=1S/C2H7NS.ClH/c3-1-2-4;/h4H,1-3H2;1H

Molecular Formula

C2H8ClNS

HBD / HBA

3 / 2

Döndürülebilir Bağlar

1

Ağır Atomlar

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hydrochloride salt of cysteamine used to treat cystinosis, a rare inherited disorder where an amino acid builds up and damages organs. It works by reducing cystine accumulation within cells.

Yes, Cysteamine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1256137. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9082. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.